Ab0482 Clinical Safety and Feasibility of a Novel Implantable Neuroimmune Modulation Device for the Treatment of Rheumatoid Arthritis
Year: 2023
Type: conference-abstract
Source: Annals of the Rheumatic Diseases
Authors: D. Peterson, M. Van Poppel, W. Boling, P. Santos, J. Schwalb, H. Eisenberg, A. Mehta, H. Spader, J. Botros, F. Vrionis, A. Ko, D. Adelson, B. Lega, P. Konrad, Y. Levine, D. Chernoff, M. Richardson
Institutions: Carolina Neurosurgery and Spine Associates, Loma Linda University, Loma Linda University Health Care, INTEGRIS Baptist Medical Center, Henry Ford Health, University of Maryland Medical Center, Feinstein Institute for Medical Research, University of New Mexico Hospital, University of Washington, Phoenix Children's Hospital, The University of Texas Southwestern Medical Center, West Virginia University Hospitals, Massachusetts General Hospital
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: bronze
Funder: Università degli Studi di Padova
OpenAlex ID: W4379648493